The MedCity INVEST Precision Medicine healthcare convention on December 9-11 attracts healthcare and life science executives and traders as we highlight progress within the improvement of diagnostics, scientific trial innovation, AI in drug improvement, and reimbursement fashions for cell and gene remedy.
10:30 AM–11:30 AM ET: Scientific Trial Design Tendencies
Distant monitoring for scientific trials has the potential to remodel scientific trial design, enabling a extra numerous pool of individuals, probably easing recruitment obstacles and assist sufferers match participation into their life. How far have we come since Pfizer’s first distant monitoring pilot? Which applied sciences/use instances are proving efficient? What are among the challenges forward?
Moderator: Frank Vinluan, Enterprise Journalist
Audio system:
Peyton Howell, EVP and Chief Industrial & Technique Officer, Parexel
Viraj Narayanan, Vice President, Life Sciences & Strategic Partnerships, COTA
Clay Williams, Founder/CEO, Medaptive Health, Inc.
12:30 –1:30 PM ET: Funding Tendencies in Precision Medication
Be a part of us for a dialogue on investments year-to-date for health-tech and life science corporations and the affect of M&A offers from 2019. How have funding methods and priorities modified? How do they work with startups/progress stage corporations? How are strategic traders altering the funding panorama? What have they realized from funding missteps and successes?
Moderator: Peter Micca, Companion, Deloitte
Audio system:
Julie Grant, Basic Companion, Canaan
Jeffrey Low, M.D., Principal, Novo Growth
Christopher McFadden, Managing Director, KKR Credit
2:30–4:00 PM ET
Pitch Excellent: Displays from Life Science Startups
Life Science corporations share completely different approaches to addressing among the ache factors in healthcare. Every startup with have Four minutes to pitch adopted by 6 minutes of Q&A with the judges.
Biomeme’s end-to-end cellular platform empowers customers to take real-time PCR in all places they want it, from pattern assortment to knowledge administration.
The corporate began out by creating the primary iPhone add-on able to performing molecular diagnostics. Since its inception, Biomeme has used superior biology and chemistry together with world-class {hardware} and software program engineering to create elegant options to complicated issues. Over time its crew has grown, and alongside the best way Biomeme has constructed the main cellular molecular diagnostics platform.
CEO: Max Perelman
Headquarters: Philadelphia, PA
EpiVario is a preclinical stage biotechnology firm that’s growing neuroepigenetic modulators to deal with reminiscence associated psychiatric issues. The corporate’s newly found epigenetic regulatory mechanism offers a goal for treating memory-related neuropsychiatric issues, because it performs a important function in consolidating trauma-induced concern and stress responses, along with cue-induced craving that underlies numerous habit issues. Based mostly on this paradigm-shifting discovering, EpiVario is growing pharmacotherapeutics to deal with nervousness and habit issues, together with PTSD and alcohol use dysfunction.
CEO: Thomas Kim
Headquarters: Philadelphia, PA
Gregor Diagnostics is a molecular diagnostics firm centered on growing a brand new screening check for prostate most cancers. Prostate most cancers screening has been a hotly debated subject during the last twenty years due to the overdiagnosis and overtreatment attributable to present screening strategies. Gregor is growing a greater answer that may restrict these points, whereas nonetheless saving males from this lethal illness.
CEO: Tobias Zutz
Headquarters: Madison, WI
SOLUtion is an early-stage life science firm growing extra affected person pleasant drug supply methods for reconstitutable medication. We particularly purpose to enhance the administration efficacy of life-saving injectable treatment with our TwistJect auto-injector for folks dwelling with adrenal insufficiency together with Addison’s Illness and Congenital Adrenal Hyperplasia.
CEO: Julia Anthony
Headquarters: Philadelphia, PA
Stingray Therapeutics is an immune oncology firm main the cost to convey the following era of recent immune oncology brokers ahead. In the present day, all our immune oncology therapeutics are in just one arm of the immune system – adaptive immunity. However the immune system has two main arms that synergistically work collectively, adaptive and innate immunity. The corporate’s program in innate immunity inhibits the direct unfavourable regulator of the key pathway, including innate immunity into the battle in opposition to most cancers, and has the promise of creating immune oncology remedy dramatically simpler.
CEO: Jonathan Northrup
Headquarters: Houston, TX
TrialSpark is a know-how firm that helps convey remedies to sufferers quicker.
In the present day, scientific trials are the bottleneck to bringing life-saving remedies to sufferers. Trials are gradual, inefficient, and costly. TrialSpark believes that it could actually use know-how to speed up the tempo of scientific trials and bridge the hole between medical analysis and sufferers who want therapy.
Consumer Development Director: Joe Zaccaria
Headquarters: New York, NY
Judges:
Wayne Barz is Chief Funding Officer, Ben Franklin Technology Partners – Northeast PA.
Rena Rosenberg is a Companion with Robin Hood Ventures
— to medcitynews.com
The post What’s coming up at MedCity INVEST Precision Medicine Day 3? appeared first on Correct Success.
source https://correctsuccess.com/investment/whats-coming-up-at-medcity-invest-precision-medicine-day-3/
No comments:
Post a Comment